Pathfinder Cell Therapy, Inc. - FORM 10-K - EX-23.1 - CONSENT - March 30, 2012

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Pathfinder Cell Therapy, Inc.Financial_Report.xls
10-K - ANNUAL REPORT - Pathfinder Cell Therapy, Inc.f10k2011_pathfinder.htm
EX-21 - LIST OF SUBSIDIARIES - Pathfinder Cell Therapy, Inc.f10k2011ex21_pathfinder.htm
EX-31.1 - CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT - Pathfinder Cell Therapy, Inc.f10k2011ex31i_pathfinder.htm
EX-32.2 - CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT - Pathfinder Cell Therapy, Inc.f10k2011ex32ii_pathfinder.htm
EX-3.2A - AMENDMENT TO BYLAWS - Pathfinder Cell Therapy, Inc.f10k2011ex3iia_pathfinder.htm
EX-31.2 - CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT - Pathfinder Cell Therapy, Inc.f10k2011ex31ii_pathfinder.htm
EX-10.2 - RESEARCH AND LICENSE AGREEMENT - Pathfinder Cell Therapy, Inc.f10k2011ex10ii_pathfinder.htm
EX-10.6 - STOCK OPTION PLAN - Pathfinder Cell Therapy, Inc.f10k2011ex10vi_pathfinder.htm
EX-10.22 - CONVERTIBLE PROMISSORY NOTE - Pathfinder Cell Therapy, Inc.f10k2011ex10vxii_pathfinder.htm
EX-10.24 - EMPLOYMENT AGREEMENT - Pathfinder Cell Therapy, Inc.f10k2011ex10xxiv_pathfinder.htm
EX-10.23 - CONVERTIBLE PROMISSORY NOTE - Pathfinder Cell Therapy, Inc.f10k2011ex10vxiii_pathfinder.htm
EX-10.24A - COMPENSATION ARRANGEMENT WITH JOHN BENSON - Pathfinder Cell Therapy, Inc.f10k2011ex10xxiva_pathfinder.htm
EX-32.1 - CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT - Pathfinder Cell Therapy, Inc.f10k2011ex32i_pathfinder.htm
EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-147184, 333-146493 and 333-19195) and Form S-8 (Registration Nos. 333-95127, 333-95129, 333-91386 and 333-134608) of Pathfinder Cell Therapy, Inc. (the "Company") of our report (which included an explanatory paragraph relating to the Company's ability to continue as a going concern) dated March 29, 2012 with respect to the financial statements of Pathfinder Cell Therapy, Inc. included in this Annual Report on Form 10-K for the year ended December 31, 2011.


/s/ EisnerAmper LLP

New York, New York
March 29, 2012

Pathfinder Cell Therapy, Inc. Reports